Kelsey

Outline: Kelsey was diagnosed with MS during college, at age 21, after experiencing blurry vision. She experiences migraines, fatigue, heat sensitivity, and urinary incontinence. Kelsey participated in a clinical trial in which she wore a smart watch and another with lots of cognitive testing. She has never been invited to participate in a trial for a medication and is not sure she would be interested in that as she is glad to be stable on her current medication.
Background: Kelsey, age 31, lives in a small city with her husband. Professionally, she works closely with MS research and health care. Kelsey identifies as a heterosexual White woman.

See full story

After being diagnosed with MS in college, Kelsey has experienced migraines, fatigue, heat sensitivity, and urinary incontinence. Kelsey has participated in a few clinical trials. In one, she had to wear a smartwatch that attempted to validate whether the difference in activity measured by the smartwatch could be an indicator of a relapse. The purpose of this trial was to understand nuanced indications of relapses and develop more sensitive tools for detection. In this trial, Kelsey had to do a timed walk everyday with her husband who served as her control. She was tested on her fine motor skills by tracing outlines. Her doctor, who invited her to participate in the study, had access to the collected data. Kelsey also participated in a clinical trial that aimed to validate a measurement of cognitive ability which entailed two one-hour appointments where she did a “bunch of cognitive testing” with a research coordinator. She remembers getting an MRI for research though she does not remember if that was a separate study or tied to the smartwatch study.

Kelsey has never been invited to participate in an MS treatment trial. However, she would consider declining treatment trials as she is hesitant to put her disease course in the hands of a researcher. If she was offered an observational or validation trial, she would be happy to accommodate a demand on her time. If she was not feeling satisfied with her current treatment regimen, she would consider a clinical trial but at this current time, she is very happy and very stable on her MS medication. Her circumstances would have to change dramatically for her to consider going off her current treatment. The main motivation for Kelsey’s participation in clinical trials is a moral one; “it's really clear to me that I have a moral obligation to support any sort of science in MS because I'm benefiting from that work already.” Kelsey believes that “science gets a lot of credit for the fact that I can live a mostly normal life now.” Kelsey has a unique experience in that she works somewhat closely with the researchers and therefore, finds it can get a little awkward when she goes into the clinic, but she does not feel any concern around sharing her data with the research team.

 

Kelsey describes how her life is different because of scientific advancements.

Kelsey describes how her life is different because of scientific advancements.

SHOW TEXT VERSION
PRINT TRANSCRIPT

I mean, for me, seeing the difference of what my life has been like on Tysabri, and I mean even on Rebif, compared to the other people, the older people in my support group, and the sort of traditional sense of what MS means, it's incredibly clear that science is completely-- like, science gets a lot of credit for the fact that I can live a mostly normal life now. I think if I had gotten diagnosed 10 years ago, my life would be very different because the drugs available would have been very different. And so, it's really clear to me that I have a moral obligation to support any sort of science in MS because I'm benefiting from that work already.

 

Kelsey talks about not wanting to change from her current medication.

Kelsey talks about not wanting to change from her current medication.

SHOW TEXT VERSION
PRINT TRANSCRIPT

Well, I think the only way I would consider it was if I did not feel satisfied with my current treatment regimen.

So, if I thought this risk of PML is too high, it makes nervous, I want to try something with a better safety profile, or if I started having relapses and was considering changing my MS medication, I think that would be the point at which I might be recruited to enroll in a clinical trial. But at this point, I'm very happy and very stable on my current MS medication. So, things would have to change pretty dramatically for me to consider going off of it.